Edition:
United Kingdom

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

41.08USD
15 Feb 2019
Change (% chg)

$0.54 (+1.33%)
Prev Close
$40.54
Open
$40.94
Day's High
$41.09
Day's Low
$40.15
Volume
47,792
Avg. Vol
45,233
52-wk High
$68.91
52-wk Low
$36.95

Chart for

About

Urogen Pharma Ltd, formerly Theracoat Ltd, is an Israel-based clinical-stage biopharmaceutical company. It is engaged in developing therapies designed to care for urological pathologies. Its lead product candidates include MitoGel and VesiGel. MiroGel is a sustained release formulation of the chemotherapy agent Mitomycin C for... (more)

Overall

Beta: --
Market Cap(Mil.): $381.96
Shares Outstanding(Mil.): 13.01
Dividend: --
Yield (%): --

Financials

  URGN.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

BRIEF-Urogen Pharma Appoints Elizabeth Barrett As President And CEO

* UROGEN PHARMA - APPOINTS ELIZABETH BARRETT AS PRESIDENT AND CEO

03 Jan 2019

Earnings vs. Estimates